Key facts
- It has raised $79.4M across 2 recorded rounds; the latest was Early Stage VC (Series A) ($79.4M) in Apr 2021.
- ValenzaBio has filed 2 Form Ds with the SEC since 2020, most recently Apr 2021 ($79.4M sold to 13 investors).
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·Watchlist + deal alerts for ValenzaBio
Create free account
No card required
Funding rounds
2 roundsApr 2021Early Stage VC (Series A)$79.4M▮
About ValenzaBio
- Industry
- Biotechnology
PA Mark — not yet priced
ValenzaBio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Pro members can request priority coverage with a 48-hour turnaround.
Recorded secondary trades
No prints on record
No secondary trades in ValenzaBio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Pro members can request priority coverage with a 48-hour turnaround.
Institutional fund marks
No fund marks yet
No SEC-registered fund has reported a fair-value mark on ValenzaBio in its N-PORT filings yet. We sweep new filings monthly.
Pro members can request priority coverage with a 48-hour turnaround.